Malden, MA, United States of America

Rajiv Kumar

This inventor holds 2 USPTO granted patents. Top assignees: Dana-Farber-Cancer Institute Inc., Northeastern University, The Brigham and Women's Hospital, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajiv Kumar. Retrieved from https://idiyas.com/inventor/rajiv-kumar-2kbqgd24

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Rajiv Kumar

Introduction

Rajiv Kumar is an accomplished inventor based in Malden, MA (US), known for his significant contributions to cancer treatment technologies. With a total of 2 patents, he has developed innovative solutions that enhance the effectiveness of cancer therapies.

Latest Patents

Kumar's latest patents include groundbreaking work in biomaterials for combined radiotherapy and immunotherapy of cancer. His first patent focuses on compositions and methods for the radiological and immunotherapeutic treatment of cancer. This invention involves metallic nanoparticles conjugated with an immunoadjuvant, which are dispersed within a biodegradable polymer matrix. This matrix can be implanted in a patient and released gradually, potentially serving as brachytherapy spacers and applicators or radiotherapy fiducial markers. The composition may be combined with marginless radiotherapy, allowing for lower doses of radiation while enhancing the immune response against cancer, including at non-irradiated sites.

His second patent involves a biopolymer-nanoparticle composite implant for tumor cell tracking. This method detects the migration of tumor cells by implanting one or more implants in a region of tumor cells. These implants consist of a biocompatible and biodegradable polymer matrix with nanoparticles functionalized to bind tumor cells. The nanoparticles bound to the tumor cells that migrate out of the region can be detected using various imaging modalities. This implant can also be shaped as a brachytherapy spacer or radiotherapy fiducial marker, providing a method of treating cancer by incorporating an anti-cancer therapeutic agent within the matrix material.

Career Highlights

Rajiv Kumar has worked with notable institutions such as Northeastern University and Dana-Farber Cancer Institute Inc. His work in these organizations has significantly contributed to the advancement of cancer treatment technologies.

Collaborations

Kumar has collaborated with esteemed colleagues, including Wilfred F Ngwa and Gerassimos M Makrigiorgos, further enhancing the impact of his research and innovations in the field of cancer therapy.

Conclusion

Rajiv Kumar's innovative patents and career achievements reflect his dedication to improving cancer treatment methodologies. His work continues to pave the way for advancements in medical technology that can significantly benefit patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…